高级检索
当前位置: 首页 > 详情页

A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations.

文献详情

资源类型:
Pubmed体系:

收录情况: ◇ 自然指数

机构: [1]Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China [2]Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA [3]Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA [4]Structural Biology Resource Center, The Rockefeller University, New York, NY 10065, USA [5]West China School of Public Health, West China Hospital, Sichuan University, Chengdu 610041, China [6]Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10065, USA [7]Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, NY 10065, USA
出处:
ISSN:

摘要:
Although there is no effective cure for chronic hepatitis B virus (HBV) infection, antibodies are protective and correlate with recovery from infection. To examine the human antibody response to HBV, we screened 124 vaccinated and 20 infected, spontaneously recovered individuals. The selected individuals produced shared clones of broadly neutralizing antibodies (bNAbs) that targeted 3 non-overlapping epitopes on the HBV S antigen (HBsAg). Single bNAbs protected humanized mice against infection but selected for resistance mutations in mice with prior established infection. In contrast, infection was controlled by a combination of bNAbs targeting non-overlapping epitopes with complementary sensitivity to mutations that commonly emerge during human infection. The co-crystal structure of one of the bNAbs with an HBsAg peptide epitope revealed a stabilized hairpin loop. This structure, which contains residues frequently mutated in clinical immune escape variants, provides a molecular explanation for why immunotherapy for HBV infection may require combinations of complementary bNAbs. Copyright © 2020 Elsevier Inc. All rights reserved.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 1 区 医学
小类 | 1 区 微生物学 1 区 寄生虫学 1 区 病毒学
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 微生物学 1 区 寄生虫学 1 区 病毒学
第一作者:
第一作者机构: [1]Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China
共同第一作者:
通讯作者:
通讯机构: [2]Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA [7]Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, NY 10065, USA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:46676 今日访问量:3 总访问量:3332 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号